deltatrials
Completed NA NCT00000722

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Pneumonia, Pneumocystis Carinii
Interventions Pentamidine isethionate
Updated 6 times since 2017 Last updated: Oct 27, 2021 Completion: Jun 30, 1991

Listed as NCT00000722, this NA trial focuses on HIV Infections and Pneumonia, Pneumocystis Carinii and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 6 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Dec 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Dec 2021 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Stony Brook, United States